Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Azimuddin Kazi

Neurology with Special Qualifications in Child Neurology Stratford, CT Medical Doctor

NPI 1750321428 CMS profile 215635

2590 Main St, Stratford, CT 06615

Open in the dashboard

General payments

$16,118

774 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Azimuddin Kazi of Stratford, CT is reported in the CMS Open Payments database as having received $16,118 across 774 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,545 125
2024 General $2,315 104
2023 General $2,579 149
2022 General $1,897 110
2021 General $4,171 118
2020 General $901 57
2019 General $1,710 111

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Azimuddin Kazi
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Azimuddin Kazi were reported at $2,545. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Azimuddin Kazi Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $1,710 $262 $68–$1,313 $163
2020 $901 $188 $46–$1,222 $114
2021 $4,171 $183 $45–$1,356 $132
2022 $1,897 $229 $72–$1,177 $149
2023 $2,579 $269 $93–$1,195 $160
2024 $2,315 $300 $98–$1,428 $164
2025 $2,545 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Supernus Pharmaceuticals, Inc. $3,558 81 payments
  2. UCB, Inc. $2,081 115 payments
  3. Tris Pharma Inc $1,413 126 payments
  4. SK Life Science, Inc. $913 51 payments
  5. Corium, Inc. $891 34 payments
  6. Argenx US, Inc. $700 28 payments
  7. Biogen, Inc. $669 39 payments
  8. Eisai Inc. $647 28 payments
  9. AbbVie, Inc. $640 30 payments
  10. ACADIA Pharmaceuticals Inc $408 19 payments
  11. Other $4,197 223 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $13,696 770 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,422 4 payments
Products named General payments · program years 2019–2025
  1. Briviact $1,389 77 payments
  2. Azstarys $891 34 payments
  3. Dyanavel XR Adhd $521 44 payments
  4. VYVGART Hytrulo $475 20 payments
  5. Leqembi $420 17 payments
  6. Dyanavel XR Adhd $418 39 payments
  7. Qelbree $386 18 payments
  8. VUMERITY $376 24 payments
  9. NUPLAZID $344 16 payments
  10. OXTELLAR XR $333 29 payments
  11. Other $7,980 447 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

774 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record